200 related articles for article (PubMed ID: 22920753)
1. Knock-down of NDRG2 sensitizes cervical cancer Hela cells to cisplatin through suppressing Bcl-2 expression.
Liu J; Yang L; Zhang J; Zhang J; Chen Y; Li K; Li Y; Li Y; Yao L; Guo G
BMC Cancer; 2012 Aug; 12():370. PubMed ID: 22920753
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-7-5p Promotes Cisplatin Resistance of Cervical Cancer Cells and Modulation of Cellular Energy Homeostasis by Regulating the Expression of the PARP-1 and BCL2 Genes.
Yang F; Guo L; Cao Y; Li S; Li J; Liu M
Med Sci Monit; 2018 Sep; 24():6506-6516. PubMed ID: 30219819
[TBL] [Abstract][Full Text] [Related]
3. NDRG2 gene expression pattern in ovarian cancer and its specific roles in inhibiting cancer cell proliferation and suppressing cancer cell apoptosis.
Kang F; Wang Y; Luo Y; Zhang Y
J Ovarian Res; 2020 Apr; 13(1):48. PubMed ID: 32345304
[TBL] [Abstract][Full Text] [Related]
4. miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells.
Xia L; Zhang D; Du R; Pan Y; Zhao L; Sun S; Hong L; Liu J; Fan D
Int J Cancer; 2008 Jul; 123(2):372-379. PubMed ID: 18449891
[TBL] [Abstract][Full Text] [Related]
5. Probing the Effects of Retinoblastoma Binding Protein 6 (RBBP6) Knockdown on the Sensitivity of Cisplatin in Cervical Cancer Cells.
Mehta H; Ambele MA; Mokgautsi N; Moela P
Cells; 2024 Apr; 13(8):. PubMed ID: 38667315
[TBL] [Abstract][Full Text] [Related]
6. Reduction of microRNA-184 by E6 oncoprotein confers cisplatin resistance in lung cancer via increasing Bcl-2.
Tung MC; Lin PL; Cheng YW; Wu DW; Yeh SD; Chen CY; Lee H
Oncotarget; 2016 May; 7(22):32362-74. PubMed ID: 27083050
[TBL] [Abstract][Full Text] [Related]
7. [MiR-503 sensitizes human hepatocellular carcinoma cells to cisplatin by targeting bcl-2].
Yang X; Yin J; Xiang Q; Xie H; Yu J; Gan R; Lei X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Jun; 42(6):605-610. PubMed ID: 28690214
[TBL] [Abstract][Full Text] [Related]
8. Effects of Livin gene RNA interference on apoptosis of cervical cancer HeLa cells and enhanced sensitivity to cisplatin.
Yu L; Wang Z
J Huazhong Univ Sci Technolog Med Sci; 2009 Oct; 29(5):625-30. PubMed ID: 19821098
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase C β inhibits autophagy and sensitizes cervical cancer Hela cells to cisplatin.
Li N; Zhang W
Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28246354
[TBL] [Abstract][Full Text] [Related]
10. [The effect of Bcl-2 gene silencing on the sensitivity of cell line A549 to chemotherapeutic drugs].
Wang JQ; Du ZW; Gao XF; Wu M; Zhang YC; Pan Y; Wang Q; Zhang GZ
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Mar; 36(3):191-7. PubMed ID: 23856142
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of miR-130a contributes to cisplatin resistance in ovarian cancer cells by targeting X-linked inhibitor of apoptosis (XIAP) directly.
Zhang X; Huang L; Zhao Y; Tan W
Acta Biochim Biophys Sin (Shanghai); 2013 Dec; 45(12):995-1001. PubMed ID: 24145606
[TBL] [Abstract][Full Text] [Related]
12. MiR-31 regulates the cisplatin resistance by targeting Src in gallbladder cancer.
Li M; Chen W; Zhang H; Zhang Y; Ke F; Wu X; Zhang Y; Weng M; Liu Y; Gong W
Oncotarget; 2016 Dec; 7(50):83060-83070. PubMed ID: 27825112
[TBL] [Abstract][Full Text] [Related]
13. miR-143 is downregulated in cervical cancer and promotes apoptosis and inhibits tumor formation by targeting Bcl-2.
Liu L; Yu X; Guo X; Tian Z; Su M; Long Y; Huang C; Zhou F; Liu M; Wu X; Wang X
Mol Med Rep; 2012 Mar; 5(3):753-60. PubMed ID: 22160209
[TBL] [Abstract][Full Text] [Related]
14. [Influence of survivin gene repression by RNA interference on the radiosensitivity and chemosensitivity to cisplatin of cervical cancer cell HeLa].
Song H; Xin XY; Xiao F; Wang DT; Han X; Guo HL
Zhonghua Fu Chan Ke Za Zhi; 2006 Aug; 41(8):554-8. PubMed ID: 17083843
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of miR-221 promotes the cisplatin-inducing apoptosis by targeting the BIM-Bax/Bak axis in breast cancer.
Ye Z; Hao R; Cai Y; Wang X; Huang G
Tumour Biol; 2016 Apr; 37(4):4509-15. PubMed ID: 26503209
[TBL] [Abstract][Full Text] [Related]
16.
Chen C; Zhou Y; Ding P; He L
Genet Test Mol Biomarkers; 2021 Aug; 25(8):540-545. PubMed ID: 34406846
[No Abstract] [Full Text] [Related]
17. Bcl-2 confers survival in cisplatin treated cervical cancer cells: circumventing cisplatin dose-dependent toxicity and resistance.
Leisching G; Loos B; Botha M; Engelbrecht AM
J Transl Med; 2015 Oct; 13():328. PubMed ID: 26474854
[TBL] [Abstract][Full Text] [Related]
18. miR-205 Promotes Apoptosis of Cervical Cancer Cells and Enhances Drug Sensitivity of Cisplatin by Inhibiting YAP1.
Li X; Li Y; Han Y; Dong B; Liu D; Che L; Liu Y; Wang Y
Cancer Biother Radiopharm; 2020 Jun; 35(5):338-344. PubMed ID: 32379984
[No Abstract] [Full Text] [Related]
19. Suppression of microRNA-454 impedes the proliferation and invasion of prostate cancer cells by promoting N-myc downstream-regulated gene 2 and inhibiting WNT/β-catenin signaling.
Fu Q; Gao Y; Yang F; Mao T; Sun Z; Wang H; Song B; Li X
Biomed Pharmacother; 2018 Jan; 97():120-127. PubMed ID: 29080452
[TBL] [Abstract][Full Text] [Related]
20. miR-503 regulates the resistance of non-small cell lung cancer cells to cisplatin by targeting Bcl-2.
Qiu T; Zhou L; Wang T; Xu J; Wang J; Chen W; Zhou X; Huang Z; Zhu W; Shu Y; Liu P
Int J Mol Med; 2013 Sep; 32(3):593-8. PubMed ID: 23856992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
